Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1958 1
1959 2
1960 3
1961 1
1962 4
1963 5
1964 9
1965 8
1966 7
1967 10
1968 6
1969 7
1970 10
1971 17
1972 11
1973 13
1974 4
1975 10
1976 13
1977 10
1978 12
1979 12
1980 15
1981 16
1982 15
1983 15
1984 14
1985 15
1986 17
1987 20
1988 13
1989 20
1990 12
1991 20
1992 18
1993 23
1994 19
1995 15
1996 15
1997 25
1998 23
1999 23
2000 17
2001 17
2002 19
2003 14
2004 14
2005 6
2006 19
2007 9
2008 9
2009 20
2010 6
2011 6
2012 13
2013 7
2014 9
2015 11
2016 9
2017 5
2018 11
2019 9
2020 4
2021 5
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

760 results

Results by year

Filters applied: . Clear all
Page 1
Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis.
Shen M, Wei Y, Kim H, Wan L, Jiang YZ, Hang X, Raba M, Remiszewski S, Rowicki M, Wu CG, Wu S, Zhang L, Lu X, Yuan M, Smith HA, Zheng A, Bertino J, Jin JF, Xing Y, Shao ZM, Kang Y. Shen M, et al. Among authors: bertino j. Nat Cancer. 2022 Jan;3(1):43-59. doi: 10.1038/s43018-021-00279-5. Epub 2021 Nov 29. Nat Cancer. 2022. PMID: 35121987 Free PMC article.
MTHFD2--a new twist?
Tedeschi PM, Scotto KW, Kerrigan J, Bertino JR. Tedeschi PM, et al. Among authors: bertino jr. Oncotarget. 2016 Feb 16;7(7):7368-9. doi: 10.18632/oncotarget.7147. Oncotarget. 2016. PMID: 26848977 Free PMC article. No abstract available.
Exploiting methionine restriction for cancer treatment.
Chaturvedi S, Hoffman RM, Bertino JR. Chaturvedi S, et al. Among authors: bertino jr. Biochem Pharmacol. 2018 Aug;154:170-173. doi: 10.1016/j.bcp.2018.05.003. Epub 2018 May 4. Biochem Pharmacol. 2018. PMID: 29733806 Review.
In cancer, all roads lead to NADPH.
Rather GM, Pramono AA, Szekely Z, Bertino JR, Tedeschi PM. Rather GM, et al. Among authors: bertino jr. Pharmacol Ther. 2021 Oct;226:107864. doi: 10.1016/j.pharmthera.2021.107864. Epub 2021 Apr 22. Pharmacol Ther. 2021. PMID: 33894275 Review.
The clopidogrel conundrum.
Bertino JS Jr. Bertino JS Jr. J Clin Pharmacol. 2014 Aug;54(8):841-2. doi: 10.1002/jcph.344. J Clin Pharmacol. 2014. PMID: 25044099 No abstract available.
Leucovorin rescue revisited.
Bertino JR. Bertino JR. J Clin Oncol. 1990 Feb;8(2):193-5. doi: 10.1200/JCO.1990.8.2.193. J Clin Oncol. 1990. PMID: 2299365 No abstract available.
The cephalosporin antibiotics.
Bertino JS Jr, Speck WT. Bertino JS Jr, et al. Pediatr Clin North Am. 1983 Feb;30(1):17-26. doi: 10.1016/s0031-3955(16)34316-4. Pediatr Clin North Am. 1983. PMID: 6338463 Review. No abstract available.
Myeloprotection with drug-resistance genes.
Banerjee D, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Lancet Oncol. 2002 Mar;3(3):154-8. doi: 10.1016/s1470-2045(02)00678-2. Lancet Oncol. 2002. PMID: 11902501 Review.
NAD+ Kinase as a Therapeutic Target in Cancer.
Tedeschi PM, Bansal N, Kerrigan JE, Abali EE, Scotto KW, Bertino JR. Tedeschi PM, et al. Among authors: bertino jr. Clin Cancer Res. 2016 Nov 1;22(21):5189-5195. doi: 10.1158/1078-0432.CCR-16-1129. Epub 2016 Aug 31. Clin Cancer Res. 2016. PMID: 27582489 Review.
760 results